NCT06710977View on ClinicalTrials.gov

To Compare the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Reducing Rates of Endophthalmitis Following Cataract Surgery.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Cataract
Interventions
DRUG

Safety of intracameral levofloxacin in cataract surgery

Intracameral levofloxacin (0.1ml/0.5mg)

DRUG

Use of intracameral cefazolin in cataract surgery

Intracameral cefazolin (0.1ml/1mg)

Trial Locations (2)

308433

Tan Tock Seng Hospital, Singapore

560723

Ang Mo Kio Specialist Center, Singapore

All Listed Sponsors
lead

Tan Tock Seng Hospital

OTHER

NCT06710977 - To Compare the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Reducing Rates of Endophthalmitis Following Cataract Surgery. | Biotech Hunter | Biotech Hunter